CN101759745A - Production process method of 16, 17 doublebond steroidal pharmaceutical intermediate - Google Patents

Production process method of 16, 17 doublebond steroidal pharmaceutical intermediate Download PDF

Info

Publication number
CN101759745A
CN101759745A CN200810153609A CN200810153609A CN101759745A CN 101759745 A CN101759745 A CN 101759745A CN 200810153609 A CN200810153609 A CN 200810153609A CN 200810153609 A CN200810153609 A CN 200810153609A CN 101759745 A CN101759745 A CN 101759745A
Authority
CN
China
Prior art keywords
reaction
processing method
compound
described processing
chromous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810153609A
Other languages
Chinese (zh)
Inventor
卢彦昌
蒋基平
周金萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Jinyao Group Co Ltd
Original Assignee
Tianjin Jinyao Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Jinyao Group Co Ltd filed Critical Tianjin Jinyao Group Co Ltd
Priority to CN200810153609A priority Critical patent/CN101759745A/en
Publication of CN101759745A publication Critical patent/CN101759745A/en
Pending legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A production process method of a 16, 17 doublebond steroidal pharmaceutical intermediate is characterized by taking 16, 17 epoxy intermediate (II) as raw material, reacting with reducing agent of chromous salt, adopting ethanol as solvent, diluting reaction liquid with large amount of water after the reaction, filtering, drying and obtaining reducer. The process can reduce the reaction step, shortens the process route, and greatly improves the quality and yield of the reducer (I).

Description

A kind of producing and manufacturing technique of 16,17 pairs of key steroid drugs intermediates
Technical field:
The present invention relates to the production method of steroid drugs intermediate.The production method of 16,17 pairs of key steroid drugs intermediates particularly.
Background technology:
The steroidal glucocorticosteroid is the important medicine of a class, and prior art shows, introduces 16 Alpha-Methyls and can significantly reduce its sodium ion retention effect (steroidal chemical fundamentals, Lin Jiwen, Chemical Industry Press, 1989.9 on the steroidal parent nucleus; 149~151), the steroid hormone with 16 Alpha-Methyls mainly contains dexamethasone etc.
16,17 pairs of key intermediates (I) are a kind of important intermediate in steroid drugs synthetic with 16 Alpha-Methyls
Traditional preparation process 16, the method of the two key intermediates (I) of 17-, need be raw material with 16,17 epoxy intermediate (II) through three step chemical reactions, through the open loop of bromine hydroxyl, debrominate, dehydration reaction, reactions steps is many, and the products obtained therefrom yield is low, and by product is many, and when carrying out debromination, to adopt the debrominate of nickel catalytic hydrogenation, need use SO during dehydration reaction 2, POCl 3Deng reagent, hydrogenation need be used highly inflammable and explosive hydrogen, and safety is not easy to guarantee, and POCl 3Instability, and can produce HCl gas excitatory, environmental pollution is serious.
Reaction process is as follows:
Figure G2008101536097D0000011
Summary of the invention:
The present invention is directed to the problems and shortcomings that prior art exists, a kind of new steroidal 16 is provided, the producing and manufacturing technique of the two key intermediates (I) of 17-is a raw material with 16,17 epoxy intermediate (II), reacts with the chromous salt reductive agent:
Figure G2008101536097D0000012
R1 is=O or-OCOCH 3
R2 is halogen or H, preferred F, Cl, Br or H; Preferred especially F, Cl or H
R3 is halogen or H, preferred F, Cl, Br or H; Preferred especially F, Cl or H
R4 is H ,-OH, or-OCOCH 3
R5 is-OH or H;
Figure G2008101536097D0000021
Expression singly-bound or two key.
This is reflected in the organic solvent and carries out, described solvent preferred alcohol.
Temperature of reaction is 0~60 ℃, preferred 10~40 ℃, and one or more in the preferred chromous acetate of described chromous salt, chromous chloride, the chromous sulfate, the mol ratio of described chromous salt and raw material is 2~10: 1.Described ethanol as solvent can be dehydrated alcohol, also can be the industrial alcohol of content 94%~96%.The envelope-bulk to weight ratio of described solvent and substrate is 5~20: 1,
Above-mentioned processing method reaction process is: compound (II) is dissolved in the organic solvent; logical protection of inert gas; under protection of inert gas, add water-soluble chromous acetate 0.05mol; react, temperature of reaction is 10~20 ℃, and reaction is after fully under protection of inert gas; reaction solution dilutes with big water gaging; filter, drying gets compound (I).
Described rare gas element is selected nitrogen, carbonic acid gas.
Adopt processing method of the present invention synthetic 16, the two key intermediates (I) of 17-, compared with prior art, the reaction conditions gentleness, avoided having the hydrogen of high risk and environment is caused severe contamination and has the application of irritating sulfurous gas, reduce reactions steps, shortened operational path, helped the raising of reaction yield and product quality simultaneously.
Embodiment:
Raw materials used content with product adopts high performance liquid chromatography to detect chromatographic column: ODS-C in the present embodiment 18, 10 μ, the stainless steel column of 4.6 * 250mm; Chromatogram column temperature: room temperature; Detect wavelength: 254nm; Moving phase: acetonitrile: water=1: 1; Flow velocity: 0.8ml/min; Sample concentration: 3mg/ml; Sample size: 2 μ L.
Embodiment 1: Compound I a's is synthetic,
Figure G2008101536097D0000022
Get compound (IIa) 10g, content 95% is dissolved in the 50ml dehydrated alcohol; nitrogen protection; add water-soluble chromous acetate 0.05mol under nitrogen protection, react, temperature of reaction is 10~20 ℃; after under nitrogen protection, reacting extremely fully; reaction solution dilutes with big water gaging, filters drying; get compound (Ia) 8.2g, content 90.1%
Embodiment 2: compounds ib synthetic
Figure G2008101536097D0000031
Get compound (IIb) 10g, content 95% is dissolved in the 100ml95% ethanol; nitrogen protection; add water-soluble chromous chloride 0.1mol under nitrogen protection, react, temperature of reaction is 20~30 ℃; after under nitrogen protection, reacting extremely fully; reaction solution dilutes with big water gaging, filters drying; get compound (Ib) 8.1g, content 90.5%
Embodiment 3: Compound I c's is synthetic
Get compound (IIc) 10g, content 95% is dissolved in the 150ml95% ethanol; nitrogen protection; add water-soluble chromous chloride 0.15mol under nitrogen protection, react, temperature of reaction is 0~10 ℃; after under nitrogen protection, reacting extremely fully; reaction solution dilutes with big water gaging, filters drying; get compound (Ic) 8.3g, content 91%
Embodiment 4: Compound I d's is synthetic
Figure G2008101536097D0000033
Get compound (IId) 10g, content 95% is dissolved in the 200ml95% ethanol; nitrogen protection; add water-soluble chromous sulfate 0.2mol under nitrogen protection, react, temperature of reaction is 30~40 ℃; after under nitrogen protection, reacting extremely fully; reaction solution dilutes with big water gaging, filters drying; compound (Id) 8.0g, content 90.3%.

Claims (9)

1. steroidal 16, the producing and manufacturing technique of the two key intermediates (I) of 17-, (II) is raw material with 16,17 epoxy intermediate, it is characterized in that, reacts as reductive agent with chromous salt in organic solvent
Figure F2008101536097C0000011
R1 is=O or-OAc;
R2 is halogen or H,
R3 is halogen or H,
R4 is H ,-OH, or-OAc;
R5 is-OH or H;
Figure F2008101536097C0000012
Expression singly-bound or two key.
2. processing method as claimed in claim 1 is characterized in that, the preferred F of R2, Cl, Br or H, the preferred F of R3, Cl, Br or H.
3. processing method as claimed in claim 1 or 2 is characterized in that described organic solvent preferred alcohol.
4. as claim 1 or 3 described processing methodes, it is characterized in that the envelope-bulk to weight ratio of described solvent and formula (I) compound is 5~20: 1.
5. as arbitrary described processing method in the claim 1 to 4, it is characterized in that described temperature of reaction is 0~60 ℃.
6. as arbitrary described processing method in the claim 1 to 5, it is characterized in that described temperature of reaction is 10~40 ℃.
7. as arbitrary described processing method in the claim 1 to 6, the mol ratio that it is characterized in that described chromous salt and formula (I) is 2~10: 1.
8. as arbitrary described processing method in the claim 1 to 7; described reaction process is: compound (II) is dissolved in the organic solvent logical protection of inert gas; under protection of inert gas, add water-soluble chromous acetate 0.05mol; react, temperature of reaction is 10~20 ℃, and reaction is after fully under protection of inert gas; reaction solution dilutes with big water gaging; filter, drying gets compound (I).
9. as arbitrary described processing method in the claim 1 to 8, it is characterized in that described rare gas element selection nitrogen, carbonic acid gas.
CN200810153609A 2008-11-28 2008-11-28 Production process method of 16, 17 doublebond steroidal pharmaceutical intermediate Pending CN101759745A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810153609A CN101759745A (en) 2008-11-28 2008-11-28 Production process method of 16, 17 doublebond steroidal pharmaceutical intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810153609A CN101759745A (en) 2008-11-28 2008-11-28 Production process method of 16, 17 doublebond steroidal pharmaceutical intermediate

Publications (1)

Publication Number Publication Date
CN101759745A true CN101759745A (en) 2010-06-30

Family

ID=42491141

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810153609A Pending CN101759745A (en) 2008-11-28 2008-11-28 Production process method of 16, 17 doublebond steroidal pharmaceutical intermediate

Country Status (1)

Country Link
CN (1) CN101759745A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979399A (en) * 2010-09-10 2011-02-23 天津金汇药业集团有限公司 Method for producing important steroid hormone dexamethasone methyl tetraenes intermediate
CN105348351A (en) * 2015-11-16 2016-02-24 浙江仙琚制药股份有限公司 Method for preparing tetraene methyl CAS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101979399A (en) * 2010-09-10 2011-02-23 天津金汇药业集团有限公司 Method for producing important steroid hormone dexamethasone methyl tetraenes intermediate
CN105348351A (en) * 2015-11-16 2016-02-24 浙江仙琚制药股份有限公司 Method for preparing tetraene methyl CAS

Similar Documents

Publication Publication Date Title
Ma et al. A water-soluble dilacunary silicotungstate as an effective catalyst for oxidation alcohols in water with hydrogen peroxide
CN110172028A (en) A kind of method of industrialized production tulobuterol
CN112778147A (en) Preparation method of 2-amino-3-methyl-5-chlorobenzoic acid
CN106831691B (en) A kind of catalysis oxidation synthetic method of heterochromatic full -4- ketone compounds
Dhoun et al. Propargylated cyanostilbene based chemodosimeter for Pd2+ with application in biological fluids
CN101759745A (en) Production process method of 16, 17 doublebond steroidal pharmaceutical intermediate
CN106986886B (en) A kind of preparation method of the fluoro- 3- Trifluoromethoxyphen-l pinacol borate of 4-
CN106831435B (en) A kind of preparation method of 1- nitros-beta naphthal derivative
Kavak et al. A luminescent anionic Cadmium (II)-MOF for the detection of nitrophenol compounds and metal ions in an aqueous solution
CN103265457B (en) A kind of synthetic method of (R)-4-aminophenethyl-(2-hydroxyl-2-styroyl)-t-butyl carbamate
CN106316935B (en) A kind of preparation method of Abemaciclib intermediate
CN110028457A (en) A kind of sulfabromomethazine and its synthetic method of stable isotope labeling
CN101265181B (en) Isomerization method for substituted aromatic nonatetraenes derivatives
CN103992277A (en) Method for preparing intermediate 4,6-dichloro-5-amino-2-propylthiouracil of ticagrelor
CN112441954B (en) Mercury ion fluorescent probe with double recognition sites
CN104311456B (en) A kind of preparation method of sulfogaiacol
CN102875399B (en) D-valine preparation method
CN113173953A (en) Purification method of high-purity lobaplatin trihydrate for preparing antitumor drugs
CN113698353B (en) Imidazolyl Schiff base fluorescence sensor for detecting copper (II) particles in aqueous solution and synthesis method thereof
CN109503426B (en) Method for purifying alpha- (o-chloroanilino) methine-beta-formamido propionitrile
CN114275769B (en) Separation of C from fullerene mixture using silver salt 60 And C 70 Is a method of (2)
CN113354628B (en) 2-styryl-3-hydroxy chromone 2-thiophenecarboxylate fluorescent probe, preparation method and application thereof
CN110305083B (en) Process for preparing 5-chloromethyl furfural from fructose
Lu et al. Iridium (I)-catalyzed deoxgenation of fluoroalkylsulfoxides with dimethyl diazomalonate to access fluoroalkylthioethers
CN116813498A (en) Fluorescent probe capable of rapidly detecting aluminum ions and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20100630